154 related articles for article (PubMed ID: 32001161)
1. Graph cluster approach in identifying novel proteins and significant pathways involved in polycystic ovary syndrome.
Afiqah-Aleng N; Altaf-Ul-Amin M; Kanaya S; Mohamed-Hussein ZA
Reprod Biomed Online; 2020 Feb; 40(2):319-330. PubMed ID: 32001161
[TBL] [Abstract][Full Text] [Related]
2. Protein-Protein Interaction Network Analysis Reveals Several Diseases Highly Associated with Polycystic Ovarian Syndrome.
Ramly B; Afiqah-Aleng N; Mohamed-Hussein ZA
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216618
[TBL] [Abstract][Full Text] [Related]
3. Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.
Dehghan Z; Mohammadi-Yeganeh S; Sameni M; Mirmotalebisohi SA; Zali H; Salehi M
Daru; 2021 Dec; 29(2):353-366. PubMed ID: 34480296
[TBL] [Abstract][Full Text] [Related]
4. Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data.
Mohamed-Hussein ZA; Harun S
Theor Biol Med Model; 2009 Sep; 6():18. PubMed ID: 19723303
[TBL] [Abstract][Full Text] [Related]
5. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
6. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
7. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
9. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology.
Zhang YY; Ma JX; Zhu YT; Wang YX; Chen WQ; Sun X; Zhang W; Wang CY; Ding CF
J Ovarian Res; 2022 Apr; 15(1):40. PubMed ID: 35379295
[TBL] [Abstract][Full Text] [Related]
13. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
14. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
[TBL] [Abstract][Full Text] [Related]
15. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
Chen Q; Zheng B; Du S; Lin Y
Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Analysis of the Biochemical Changes in Rats with Polycystic Ovary Syndrome (PCOS) Using Urinary 1H NMR-Based Metabonomics.
Huang W; Li S; Luo N; Lu K; Ban S; Lin H
Horm Metab Res; 2020 Jan; 52(1):49-57. PubMed ID: 31945791
[TBL] [Abstract][Full Text] [Related]
18. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.
Roldán B; San Millán JL; Escobar-Morreale HF
Am J Pharmacogenomics; 2004; 4(2):93-107. PubMed ID: 15059032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
